Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-062854
Filing Date
2012-12-06
Accepted
2012-12-06 16:42:16
Documents
1
Period of Report
2012-12-04

Document Format Files

Seq Description Document Type Size
1 DECEMBER 2012 APPLE EXERCISE rrd362369.html 4  
1 DECEMBER 2012 APPLE EXERCISE rrd362369.xml 4 6801
  Complete submission text file 0001181431-12-062854.txt   8518
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Issuer) CIK: 0001016169 (see all company filings)

EIN.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INKLINE PHARMACEUTICAL CO INC SENTRY PARK EAST 1720 WALTON ROAD BLUE BELL PA 19422
Business Address
APPLE ROBERT F (Reporting) CIK: 0001054942 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32302 | Film No.: 121247138